Two Sigma Investments
CNSP icon

Two Sigma Investments’s CNS Pharmaceuticals CNSP Stock Holding History

Two Sigma Investments’s Portfolio CNSP Stock Details CNSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-155
Closed -$11.2K – 3248
2024
Q4 		$11.2K Buy
+155
New +$11K ﹤0.01% 3130
2022
Q2 		– Hold
0
– -$9K – 2573
2022
Q1 		– Hold
0
– – – 2539

Other funds holding CNSP

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BC
Barrett & Company Providence, Rhode Island $357M AUM 22.45% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments's CNSP Position: Q1 2025 in Review

Two Sigma Investments sold out of CNS Pharmaceuticals (CNSP) in Q1 2025, closing a stake of 155 shares — an estimated $11.2K sold.

Two Sigma Investments first reported a position in CNSP in Q4 2024 and held it in 1 quarter. The position peaked at $11.2K in Q4 2024. 7 funds tracked by Wall St. Rank hold CNSP as of Q1 2025.

  • Two Sigma Investments reported no remaining CNS Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Investments sold 155 CNS Pharmaceuticals shares in Q1 2025, an estimated $11.2K.
  • Two Sigma Investments first reported a position in CNS Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Two Sigma Investments's CNS Pharmaceuticals position peaked at $11.2K in Q4 2024.
  • 7 funds tracked by Wall St. Rank held CNS Pharmaceuticals as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.